Financing
Proceeds from convertible debt
Guardant Health Proceeds from convertible debt remained flat by 0.0% to $100.63M in Q4 2025 compared to the prior quarter.
Analysis
StatementCash Flow Statement
SectionFinancing
First reportedQ1 2018
Last reportedQ4 2025Feb 19, 2026
Metric ID:
amd_proceeds_from_convertible_debtHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $0 | $402.5M |
Range$0 – $402.5M
Proceeds from convertible debt at Other Companies
Frequently Asked Questions
- What is Guardant Health's proceeds from convertible debt?
- Guardant Health (GH) reported proceeds from convertible debt of $100.63M in Q4 2025.